Chondrosarcomas revisited.

Area of Science:

• Orthopedic Oncology
• Skeletal Radiology
• Surgical Pathology

Background:

• Chondrosarcomas are malignant bone tumors originating from hyaline cartilage.
• They exhibit diverse behavior, from indolent to aggressive, with varying metastatic potential.
• Clinical presentation often involves persistent pain or palpable masses, with symptoms developing over months to years.

Purpose of the Study:

• To provide a comprehensive overview of chondrosarcoma diagnosis, classification, and management.
• To highlight key radiographic and histologic features differentiating chondrosarcomas from benign cartilaginous lesions.
• To outline current treatment strategies based on tumor grade and location.

Main Methods:

• Review of radiographic findings including bone expansion, matrix calcifications, cortical destruction, and soft tissue extension.
• Histopathological analysis focusing on cellularity, nuclear atypia, pleomorphism, and mitotic activity.
• Evaluation of treatment outcomes based on surgical modalities (wide resection, curettage) and adjuvant therapies (chemotherapy, radiation).

Main Results:

• Radiographic hallmarks include bone expansion, characteristic matrix calcifications, and potential cortical destruction.
• Histological diagnosis relies on increased cellularity, nuclear atypia, and evidence of bone permeation.
• Treatment success is correlated with surgical approach; wide resection for high-grade/pelvic tumors, and intralesional surgery with adjuvant therapy for low-grade tumors.

Conclusions:

• Chondrosarcoma management requires a multidisciplinary approach integrating radiology, pathology, and orthopedic oncology.
• Accurate grading and staging are crucial for determining optimal treatment strategies.
• Surgical intervention remains the cornerstone of treatment, with adjuvant therapies playing a role in specific subtypes and situations.